Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: A contributing factor to adynamic bone disease?

International Urology and Nephrology

Volumn 38, Issue 2, 2006, Pages 317-322

  Wei, Mingxin ^a,b   Esbaei, Khaled ^a,c   Bargman, Joanne M ^a   Oreopoulos, Dimitrios G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Guangxi People's Hospital   (China)

^c UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

Adynamic bone disease; Magnesium; Parathyroid hormone; Peritoneal dialysis; Phosphate binders

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CARBONATE; DIALYSIS FLUID; LACTIC ACID; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; SEVELAMER;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BONE DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; FEMALE; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; MAGNESIUM BLOOD LEVEL; MALE; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PERITONEAL DIALYSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BONE DISEASES; CALCIUM; DIALYSIS SOLUTIONS; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 33746516772     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-0082-6     Document Type: Article

References (56)

1. MM Salem 1997 Hyperparathyroidism in the hemodialysis population: A survey of 612 patients Am J Kidney Dis 29 6 862-865 9186071 1:STN:280:ByiA38blvFM%3D
2. JF Navarro ML Macia E Gallego et al. 1997 Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol 31 3 275-280 9249893 1:STN:280:ByiA1MzjvVM%3D
3. MS Cho KS Lee YK Lee et al. 2002 Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate Korean J Intern Med 17 2 114-121 12164088 1:CAS:528:DC%2BD38XmsVWltb8%3D
4. JF C Navarro Mora M Macia et al. 1999 Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients Perit Dial Int 19 5 455-461
5. JF Navarro C Mora A Jimenez et al. 1999 Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients Am J Kidney Dis 34 1 43-48 10401014 1:STN:280:DyaK1MzjtV2jug%3D%3D
6. 2+ and other ions as extracellular (first) messengers Physiol Rev 71 2 371-411 2006218 1:CAS:528:DyaK3MXisVSksrk%3D
7. O Ferment PE Garnier Y Touitou 1987 Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man J Endocrinol 113 1 117-122 3585222 1:CAS:528:DyaL2sXhsFSjsrw%3D
8. KP Katopodis EL Koliousi EK Andrikos et al. 2003 Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: Role of the dialysate magnesium concentration Artif Organs 27 9 853-857 12940910 10.1046/j.1525-1594.2003.07193.x
9. AA Ejaz AP McShane VC Gandhi et al. 1995 Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution Perit Dial Int 15 1 61-64 7734563 1:STN:280:ByqB2M3jsVU%3D
10. AJ Hutchison AJ Were HF Boulton et al. 1996 Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations Nephron 72 1 52-58 8903861 1:CAS:528:DyaK28XhtVWqsrc%3D
11. H Malluche MC Faugere 1990 Renal bone disease 1990: An unmet challenge for the nephrologist Kidney Int 38 2 193-211 2205749 1:STN:280:By%2BA1cvgvVE%3D
12. DJ Sherrard G Hercz Y Pei et al. 1993 The spectrum of bone disease in end-stage renal failure - an evolving disorder Kidney Int 43 2 436-442 8441240 1:STN:280:ByyC1c%2FjvVc%3D
13. D Zayour M Daouk W Medawar et al. 2004 Predictors of bone mineral density in patients on hemodialysis Transplant Proc 36 5 1297-1301 15251316 1:STN:280:DC%2BD2czkvFGisQ%3D%3D 10.1016/ j.transproceed.2004.05.069
14. GB Spasovski AR Bervoets GJ Behets et al. 2003 Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis Nephrol Dial Transplant 18 6 1159-1166 12748350 1:CAS:528:DC%2BD3sXjvFCmtbg%3D 10.1093/ndt/gfg116
15. A Gal-Moscovici MM Popovtzer 2002 Parathyroid hormone-independent osteoclastic resorptive bone disease: A new variant of adynamic bone disease in haemodialysis patients Nephrol Dial Transplant 17 4 620-624 11917055 1:CAS:528:DC%2BD38XjsFGjs7s%3D 10.1093/ndt/17.4.620
16. MM Couttenye PC D'Haese WJ Verschoren et al. 1999 Low bone turnover in patients with renal failure Kidney Int Suppl 73 S70-76 10633468 1:STN:280:DC%2BD3c%2FpvFartw%3D%3D 10.1046/j.1523-1755.1999.07308.x
17. T Akizawa E Kinugasa T Akiba et al. 1997 Incidence and clinical characteristics of hypoparathyroidism in dialysis patients Kidney Int Suppl 62 S72-74 9350686 1:STN:280:DyaK1c%2FhtFOrug%3D%3D
18. A Torres V Lorenzo D Hernandez et al. 1995 Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH Kidney Int 47 5 1434-1442 7637272 1:STN:280:ByqA28vivVc%3D
19. D Hernandez MT Concepcion V Lorenzo 1994 Adynamic bone disease with negative aluminium staining in predialysis patients: Prevalence and evolution after maintenance dialysis Nephrol Dial Transplant 9 5 517-523 7522307 1:STN:280:ByuA2sjgtV0%3D
20. G Hercz Y Pei C Greenwood et al. 1993 Aplastic osteodystrophy without aluminum: The role of "suppressed" parathyroid function Kidney Int 44 4 860-866 8258962 1:STN:280:ByuD1c7msVQ%3D
21. H Ito E Kinugasa 2004 Pathogenesis of secondary hyperparathyroidism and renal bone disease Clin Calcium 14 5 720-725 15577032
22. K Shiizaki S Sumikado T Akizawa 2004 Low PTH level and adynamic bone disease in dialysis patients Clin Calcium 14 1 16-20 15576948 1:CAS:528:DC%2BD2cXhvFGhuro%3D
23. G Coen 2005 Adynamic bone disease: An update and overview J Nephrol 18 2 117-122 15931639
24. MM Couttenye PC D'Haese WJ Verschoren et al. 1999 Low bone turnover in patients with renal failure Kidney Int Suppl 73 S70-76 10633468 1:STN:280:DC%2BD3c%2FpvFartw%3D%3D 10.1046/j.1523-1755.1999.07308.x
25. S Ghitu R Oprisiu L Benamar et al. 2000 Renal osteodystrophy (3); its treatment in dialysis patients Nephrologie 21 8 413-424 11213385 1:STN:280:DC%2BD3M7is12qtg%3D%3D
26. E Slatopolsky A Brown A Dusso 2005 Calcium, phosphorus and vitamin D disorders in uremia Contrib Nephrol 149 261-271 15876849 1:CAS:528:DC%2BD2MXhtVWrurvJ
27. X Yu Y Sabbagh SI Davis et al. 2005 Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations Bone 36 6 971-977 15869926 1:CAS:528:DC%2BD2MXltFSltL4%3D 10.1016/ j.bone.2005.03.002
28. E Slatopolsky J Finch M Denda et al. 1996 Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro J Clin Invest 97 11 2534-2540 8647946 1:CAS:528:DyaK28XjsFKjsL4%3D
29. J Silver C Yalcindag A Sela-Brown et al. 1999 Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate Kidney Int Suppl 73 S2-7 10633456 1:CAS:528:DC%2BD3cXivFKisQ%3D%3D 10.1046/ j.1523-1755.1999.07310.x
30. T Naveh-Many J Silver 1990 Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat J Clin Invest 86 4 1313-1319 2212016 1:CAS:528:DyaK3cXmt1Gisro%3D
31. E Slatopolsky 1998 The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism Nephrol Dial Transplant 13 Suppl 3 3-8 9568812 10.1093/ndt/13.suppl_3.3
32. J Silver T Naveh-Many 1994 Regulation of parathyroid hormone synthesis and secretion Semin Nephrol 14 2 175-194 8177983 1:CAS:528:DyaK2cXjtFGqs7g%3D
33. P Pietschmann W Woloszczuk H Pietschmann 1990 Increased serum osteocalcin levels in elderly females with vitamin D deficiency Exp Clin Endocrinol 95 2 275-278 2365024 1:STN:280:By%2BA3cnisFQ%3D
34. MS Calvo R Kumar H Heath 1990 Persistently elevated parathyroid hormone secretion and action in young women after 4 weeks of ingesting high phosphorus, low calcium diets J Clin Endocrinol Metab 70 5 1334-1340 2335575 1:CAS:528:DyaK3cXktVGjsbg%3D
35. LY Sun M Wang L Yang 2005 Study of calcium-phosphorous metabolism and intact parathyroid hormone levels in end stage renal disease patients Beijing Da Xue Xue Bao 37 2 147-150 15841142 1:CAS:528:DC%2BD2MXhtFGksrzP
36. IN Cholst SF Steinberg PJ Tropper et al. 1984 The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects N Engl J Med 310 19 1221-1225 6709029 1:CAS:528:DyaL2cXktFOgsrs%3D
37. O Ferment PE Garnier Y Touitou 1987 Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man J Endocrinol 113 1 117-122 3585222 1:CAS:528:DyaL2sXhsFSjsrw%3D
38. IR Gough GA Balderson HM Lloyd et al. 1988 The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism World J Surg 12 4 463-469 3420930 1:STN:280:BieA3sjnvFI%3D 10.1007/BF01655421
39. JA Delmez J Kelber KY Norword et al. 1996 Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study Kidney Int 49 1 163-167 8770963 1:STN:280:BymA28nosV0%3D
40. V Parsons D Baldwin C Moniz et al. 1993 Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders Nephron 63 4 379-383 8459870 1:STN:280:ByyB3M7ltVM%3D
41. P Nilsson SG Johansson BG Danielson 1984 Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium Nephron 37 1 25-29 6717701 1:STN:280:BiuC1M7nsFw%3D
42. S Takahashi K Okada M Yanai 1994 Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients Perit Dial Int 14 1 75-78 8312420 1:STN:280:ByuC2cnhsl0%3D
43. P Pletka DS Bernstein CL Hampers et al. 1974 Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis Metabolism 23 7 619-630 4600477 1:STN:280:CSuB283ms1c%3D
44. RJ McGonigle MJ Weston J Keenan et al. 1984 Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy Magnesium 3 1 1-7 6482508 1:STN:280:BiqD3M7js1M%3D
45. T Gohda I Shou M Fukui et al. 2002 Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients Am J Kidney Dis 39 6 1255-1260 12046039 1:CAS:528:DC%2BD38XkvFGgtrg%3D 10.1053/ ajkd.2002.33399
46. JY Guh HC Chen HY Chuang et al. 2002 Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients Am J Kidney Dis 39 6 1245-1254 12046038 10.1053/ajkd.2002.33398
47. C Sanchez F Lopez-Barea J Sanchez-Cabezudo et al. 2004 Low vs standard calcium dialysate in peritoneal dialysis: Differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study Nephrol Dial Transplant 19 6 1587-1593 15069173 1:CAS:528:DC%2BD2cXkt1SqsrY%3D 10.1093/ndt/gfh214
48. HH Saha AP Harmoinen AI Pasternack 1997 Measurement of serum ionized magnesium in CAPD patients Perit Dial Int 17 4 347-352 9284461 1:STN:280:ByiH3s%2Fhs1Q%3D
49. JF Navarro C Mora J Garcia et al. 1998 Hypermagnesemia in CAPD. Relationship with parathyroid hormone levels Perit Dial Int 18 1 77-80 9527035 1:STN:280:DyaK1c7os1agsw%3D%3D
50. H Miki PB Maercklein LA Fitzpatrick 1997 Effect of magnesium on parathyroid cells: Evidence for two sensing receptors or two intracellular pathways? Am J Physiol 272 1 Pt 1 E1-6 9038844 1:CAS:528:DyaK2sXhtFKkt7g%3D
51. SG Massry JW Coburn CR Kleeman 1970 Evidence for suppression of parathyroid gland activity by hypermagnesemia J Clin Invest 49 9 1619-1629 5449702 1:CAS:528:DyaE3cXltFyitLs%3D
52. R O'Donovan D Baldwin M Hammer et al. 1986 Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia Lancet 1 8486 880-882 2870354 1:STN:280:BimC2szns1c%3D 10.1016/ S0140-6736(86)90987-6
53. GM Shah RL Winer RE Cutler et al. 1987 Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis Am J Kidney Dis 10 4 268-275 3661548 1:STN:280:BieD387gtVw%3D
54. H Roujouleh S Lavaud O Toupance et al. 1987 Magnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload Nephrol 8 2 45-50 1:STN:280:BiiB1cjltVQ%3D
55. RD Lindeman 1986 Chronic renal failure and magnesium metabolism Magnesium 5 5-6 293-300 3807422 1:CAS:528:DyaL2sXkslyrsg%3D%3D
56. AP Guillot VL Hood CF Runge et al. 1982 The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis Nephron 30 2 114-117 7099318 1:STN:280:Bi2B2crmvVQ%3D